Antiatherosclerotic Effects of Sodium-Glucose Cotransporter 2 Inhibitors: An Underrecognized Piece of the Big Puzzle? Koufakis T, Vas P, Maltese G, Kotsa K, et al. J Clin Endocrinol Metab 2022;107:e4244-e4245.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Koufakis T, Vas P, Maltese G, Kotsa K, et al. Antiatherosclerotic Effects of Sodium-Glucose Cotransporter 2 Inhibitors: An Underrecognized Piece of the Big Puzzle? J Clin Endocrinol Metab 2022;107:e4244-e4245.
PMID: 35245937